Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rapport Therapeutics, Inc.

9.99
+2.8439.72%
Post-market: 9.77-0.2200-2.20%19:57 EST
Volume:1.24M
Turnover:11.96M
Market Cap:365.40M
PE:-1.72
High:10.85
Open:6.63
Low:6.43
Close:7.15
Loading ...

Rapport Therapeutics Inc trading resumes

TIPRANKS
·
Yesterday

Rapport Therapeutics Appoints New CMO Amid Phase 2a Updates

TIPRANKS
·
03 Mar

Rapport Therapeutics : Intends to Initiate Additional Phase 2a Trial of Rap-219 in Bipolar Mania in Q3 2025 With Topline Data Expected in H1 of 2027

THOMSON REUTERS
·
03 Mar

Rapport Therapeutics Announces Appointment of DR. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

THOMSON REUTERS
·
03 Mar

Press Release: Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Dow Jones
·
03 Mar

Rapport Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
24 Feb

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
11 Feb

Promising Clinical Trial Results and Stable Leadership Secure Buy Rating for Rapport Therapeutics

TIPRANKS
·
10 Jan

Stifel Nicolaus Remains a Buy on Rapport Therapeutics, Inc. (RAPP)

TIPRANKS
·
10 Jan

Rapport Therapeutics Reports Positive Early Data for Epilepsy Drug Candidate

MT Newswires Live
·
10 Jan

Rapport Therapeutics announces new Phase 1 data for RAP-219

TIPRANKS
·
09 Jan

Rapport Therapeutics Inc - Phase 2a Trial of Rap-219 on Track, Data Expected Mid-2025

THOMSON REUTERS
·
09 Jan

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting Rap-219'S Transformative Potential for CNS Disorders

THOMSON REUTERS
·
09 Jan

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

GlobeNewswire
·
09 Jan

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Jefferies

TIPRANKS
·
09 Dec 2024

Companies Like Rapport Therapeutics (NASDAQ:RAPP) Can Afford To Invest In Growth

Simply Wall St.
·
07 Dec 2024